Durdiakova J, Ostatnikova D, Celec P. Testosterone and its metabolites–modulators of brain functions. Acta Neurobiol Exp (Wars). 2011;71:434–54.

PubMed  Google Scholar 

Li Z, Wang M, Hua M, Wang Z, Ying Y, Zhang Z, et al. Association between testosterone and cancers risk in women: a two-sample Mendelian randomization study. Discov Oncol. 2023;14:198.

PubMed  PubMed Central  CAS  Google Scholar 

Klap J, Loughlin KR. Re: Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia, Abraham Morgentaler. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol. 2014;65:115–23.

Google Scholar 

Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab. 1981;53:58–68.

PubMed  CAS  Google Scholar 

Tiefenbacher K, Daxenbichler G. The role of androgens in normal and malignant breast tissue. Breast Care (Basel). 2008;3:325–31.

PubMed  Google Scholar 

Simpson ER. Aromatization of androgens in women: current concepts and findings. Fertil Steril. 2002;77(Suppl 4):S6-10.

PubMed  Google Scholar 

Burger HG. Androgen production in women. Fertil Steril. 2002;77(Suppl 4):S3-5.

PubMed  Google Scholar 

Dimitrakakis C, Zhou J, Bondy CA. Androgens and mammary growth and neoplasia. Fertil Steril. 2002;77(Suppl 4):S26-33.

PubMed  Google Scholar 

Somboonporn W, Davis SR. Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev. 2004;25(3):374–88.

PubMed  CAS  Google Scholar 

Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–57.

PubMed  PubMed Central  CAS  Google Scholar 

Iversen OH. Kinetics of cellular proliferation and cell loss in human carcinomas. A discussion of methods available for in vivo studies. Eur J Cancer. 1965;1967(3):389–94.

Google Scholar 

Schernhammer ES, Sperati F, Razavi P, Agnoli C, Sieri S, Berrino F, et al. Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort. Breast Cancer Res. 2013;15:R46.

PubMed  PubMed Central  CAS  Google Scholar 

Yu H, Shu XO, Shi R, Dai Q, Jin F, Gao YT, et al. Plasma sex steroid hormones and breast cancer risk in Chinese women. Int J Cancer. 2003;105:92–7.

PubMed  CAS  Google Scholar 

Farhat GN, Cummings SR, Chlebowski RT, Parimi N, Cauley JA, Rohan TE, et al. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers. J Natl Cancer Inst. 2011;103:562–70.

PubMed  PubMed Central  CAS  Google Scholar 

Glaser RL, Dimitrakakis C. Reduced breast cancer incidence in women treated with subcutaneous testosterone, or testosterone with anastrozole: a prospective, observational study. Maturitas. 2013;76:342–9.

PubMed  CAS  Google Scholar 

Glaser R, Dimitrakakis C. Reduced incidence of breast cancer in women adherent to testosterone or testosterone-anastrozole hormone therapy: updated interim analysis. Maturitas. 2015;81:189.

Google Scholar 

Vera-Badillo FE, Templeton AJ, de Gouveia P, Diaz-Padilla I, Bedard PL, Al-Mubarak M, et al. Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:djt319.

PubMed  Google Scholar 

Collins LC, Cole KS, Marotti JD, Hu R, Schnitt SJ, Tamimi RM. Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses’ Health Study. Mod Pathol. 2011;24:924–31.

PubMed  PubMed Central  Google Scholar 

Ruth KS, Day FR, Tyrrell J, Thompson DJ, Wood AR, Mahajan A, et al. Using human genetics to understand the disease impacts of testosterone in men and women. Nat Med. 2020;26:252–8.

PubMed  PubMed Central  CAS  Google Scholar 

Hayes BL, Robinson T, Kar S, Ruth KS, Tsilidis KK, Frayling T, et al. Do sex hormones confound or mediate the effect of chronotype on breast and prostate cancer? A Mendel Randomization Study PLoS Genet. 2022;18: e1009887.

CAS  Google Scholar 

Zhang H, Ahearn TU, Lecarpentier J, Barnes D, Beesley J, Qi G, et al. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nat Genet. 2020;52:572–81.

PubMed  PubMed Central  CAS  Google Scholar 

Tin Tin S, Reeves GK, Key TJ. Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank. Br J Cancer. 2021;125:126–34.

PubMed  PubMed Central  CAS  Google Scholar 

Nounu A, Kar SP, Relton CL, Richmond RC. Sex steroid hormones and risk of breast cancer: a two-sample Mendelian randomization study. Breast Cancer Res. 2022;24:66.

PubMed  PubMed Central  CAS  Google Scholar 

Yersal O, Barutca S. Biological subtypes of breast cancer: Prognostic and therapeutic implications. World J Clin Oncol. 2014;5:412–24.

PubMed  PubMed Central  Google Scholar 

Ermis Akyuz E, Bell SM. The diverse role of CUB and sushi multiple domains 1 (CSMD1) in human diseases. Genes. 2022;13(12):2332.

PubMed  PubMed Central  CAS  Google Scholar 

Burgess SJ, Gibbs H, Toomes C, Coletta PL, Bell SM. The role of csmd1 during mammary gland development. Genes. 2021;12(2):162.

PubMed  PubMed Central  CAS  Google Scholar 

Kamal M, Holliday DL, Morrison EE, Speirs V, Toomes C, Bell SM. Loss of CSMD1 expression disrupts mammary duct formation while enhancing proliferation, migration and invasion. Oncol Rep. 2017;38:283–92.

PubMed  CAS  Google Scholar 

Ma C, Quesnelle KM, Sparano A, Rao S, Park MS, Cohen MA, et al. Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues. Cancer Biol Ther. 2009;8:907–16.

PubMed  CAS  Google Scholar 

Chen H, Fan S, Stone J, Thompson DJ, Douglas J, Li S, et al. Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci. Breast Cancer Res. 2022;24:27.

PubMed  PubMed Central  Google Scholar 

Stone J, Thompson DJ, Dos Santos SI, Scott C, Tamimi RM, Lindstrom S, et al. Novel associations between common breast cancer susceptibility variants and risk-predicting mammographic density measures. Cancer Res. 2015;75:2457–67.

PubMed  PubMed Central  CAS  Google Scholar 

Watanabe K, Yamamoto S, Sakaguti S, Isayama K, Oka M, Nagano H, et al. A novel somatic mutation of SIN3A detected in breast cancer by whole-exome sequencing enhances cell proliferation through ERalpha expression. Sci Rep. 2018;8:16000.

PubMed  PubMed Central  Google Scholar 

Lu M, Zhang Y, Yang F, Mai J, Gao Q, Xu X, et al. TWAS Atlas: a curated knowledgebase of transcriptome-wide association studies. Nucleic Acids Res. 2023;51:D1179–87.

PubMed  CAS  Google Scholar 

Zaharija B, Samardžija B, Bradshaw NJ. The TRIOBP isoforms and their distinct roles in actin stabilization, deafness, mental illness, and cancer. Molecules. 2020;25(21):4967.

PubMed  PubMed Central  CAS  Google Scholar 

Wesdorp M, van de Kamp JM, Hensen EF, Schraders M, Oostrik J, Yntema HG, et al. Broadening the phenotype of DFNB28: mutations in TRIOBP are associated with moderate, stable hereditary hearing impairment. Hear Res. 2017;347:56–62.

PubMed  CAS  Google Scholar 

Bao J, Wang S, Gunther LK, Kitajiri S, Li C, Sakamoto T. The actin-bundling protein TRIOBP-4 and -5 promotes the motility of pancreatic cancer cells. Cancer Lett. 2015;356:367–73.

PubMed  CAS  Google Scholar 

Wang H, Li K, Mei Y, Huang X, Li Z, Yang Q, et al. Sp1 suppresses miR-3178 to promote the metastasis invasion cascade via upregulation of TRIOBP. Mol Ther Nucleic Acids. 2018;12:1–11.

PubMed  PubMed Central  Google Scholar 

Tsachaki M, Odermatt A. Subcellular localization and membrane topology of 17beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol. 2019;489:98–106.

PubMed  CAS  Google Scholar 

Handelsman DJ, Hirschberg AL, Bermon S. Circulating testosterone as the hormonal basis of sex differences in athletic performance. Endocr Rev. 2018;39:803–29.

PubMed  PubMed Central